🇺🇸 FDA
Patent

US 10695320

Compositions comprising urolithin compounds

granted A61KA61K31/366A61K47/14

Quick answer

US patent 10695320 (Compositions comprising urolithin compounds) held by Amazentis SA expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Amazentis SA
Grant date
Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/366, A61K47/14, A61K47/24, A61K9/08